EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Monocytic reactive oxygen species–induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine

Sandrine Gimenez, Emna Hamrouni, Sonia André, Morgane Picard, Calayselvy Soundaramourty, Claire Lozano, Thierry Vincent, Tu-Anh Tran, Lucy Kundura, Jérôme Estaquier, Pierre Corbeau

Journal of Allergy and Clinical Immunology · 2025

DOI: 10.1016/j.jaci.2025.01.003 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Sandrine Gimenez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Genetics, Molecular Bases of Human Diseases, UMR9002, CNRS and Montpellier University, Montpellier, France. Hauptthemen laut MEDLINE: Apoptosis, COVID-19, COVID-19 Vaccines, Immunity, Cellular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: CHU de Nîmes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: We have recently shown that during acute severe coronavirus disease 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein induces a cascade of events resulting in T-cell apoptosis. Indeed, by neutralizing the protease activity of its receptor, angiotensin-converting enzyme 2, S protein induces an increase in circulating angiotensin II (AngII), resulting in monocytic release of reactive oxygen species (ROS) and programmed T-cell death. OBJECTIVE: Here, we tested whether SARS-CoV-2 mRNA vaccines, known to cause the circulation of the vaccine antigen, S protein receptor binding domain (RBD), might trigger the same cascade. METHODS: We used ELISA to quantify the presence of RBD and AngII in peripheral blood of participants and the presence of IFN-γ in the supernatant of PBMCs exposed to S protein. Monocytic ROS production, T-cell apoptosis, and S protein-induced T-lymphocyte proliferation were measured by flow cytometry, and DNA damage was measured by immunofluorescence. RESULTS: In most vaccinees, we observed that the presence of circulating RBD peaked on day 14 and was linked to an increase in AngII plasma levels with a peak on day 28. This increase correlated with the ability of monocytes to produce ROS and to induce ROS-mediated DNA damage in neighboring cells, including PBMCs; CD4+ and CD8+ T-lymphocyte apoptosis; and a poor response to protein S in vitro from both CD4+ and CD8+ T cells. CONCLUSIONS: We observed the same cascade of events triggered by the vaccinal antigen as by SARS-CoV-2 infection. This cascade may account for the suboptimal efficiency of mRNA SARS-CoV-2 vaccines in preventing the infection, the limited vaccine memory, and certain side effects. In this model, AngII receptor antagonists and/or antioxidants might improve the performance of the SARS-CoV-2 vaccine. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05655351.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisCOVID-19COVID-19 VaccinesImmunity, CellularMonocytesReactive Oxygen SpeciesSARS-CoV-2T-LymphocytesAdultFemaleHumansMaleMiddle AgedCD4-Positive T-LymphocytesInterferon-gammaSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

DNA damageSARS-CoV-2 spikeT-cell responseoxidative stressprogrammed T-cell death

Substanzen

COVID-19 VaccinesInterferon-gammaReactive Oxygen SpeciesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Human Genetics, Molecular Bases of Human Diseases, UMR9002, CNRS and Montpellier University, Montpellier, France.
  • Université de Paris, INSERM U1124, Mort Cellulaire dans les Interactions Hôte-Pathogène, Paris, France.
  • Immunology Department, University Hospital, Montpellier, France.
  • Immunology Department, University Hospital, Montpellier, France; Montpellier University, Montpellier, France.
  • Montpellier University, Montpellier, France; Pediatrics Department, University Hospital, Nîmes, France.
  • Université de Paris, INSERM U1124, Mort Cellulaire dans les Interactions Hôte-Pathogène, Paris, France; CHU de Québec-Université Laval Research Center, Department of Microbiology and Immunology, Québec City, Québec, Can…

Förderung

  • CHU de Nîmes

Zitieren

APA

Gimenez, S., Hamrouni, E., André, S., Picard, M., Soundaramourty, C., Lozano, C., Vincent, T., Tran, T. A., Kundura, L., Estaquier, J., & Corbeau, P. (2025). Monocytic reactive oxygen species–induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.01.003

Vancouver

Gimenez S, Hamrouni E, André S, Picard M, Soundaramourty C, Lozano C, et al. Monocytic reactive oxygen species–induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2025.01.003

BibTeX
@article{Gimenez2025,
  author = {Gimenez, Sandrine and Hamrouni, Emna and André, Sonia and Picard, Morgane and Soundaramourty, Calayselvy and Lozano, Claire and Vincent, Thierry and Tran, Tu-Anh and Kundura, Lucy and Estaquier, Jérôme and Corbeau, Pierre},
  title = {Monocytic reactive oxygen species–induced T-cell apoptosis impairs cellular immune response to SARS-CoV-2 mRNA vaccine},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.jaci.2025.01.003}
}
Kostenlos starten →